Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (39)
Tae Seop Lim, Ho Soo Chun, Soon Sun Kim, Ja Kyung Kim, Minjong Lee, Hyo Jung Cho, Seung Up Kim & Jae Youn Cheong. (2023) Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes. Gut and Liver 17:4, pages 610-619.
Crossref
Crossref
Yilian Xie, Kai Huang, Xiangyu Zhang, Zhouxiao Wu, Yiyi Wu, Jinguo Chu, Weiliang Kong & Guoqing Qian. (2023) Association of serum uric acid-to-high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease in American adults: a population-based analysis. Frontiers in Medicine 10.
Crossref
Crossref
Heze Fan, Chenbo Xu, Wenyuan Li, Yuzhi Huang, Rui Hua, Ying Xiong, Yuxuan Yang, Xueying Feng, Zihao Wang, Zuyi Yuan & Juan Zhou. (2022) Ideal Cardiovascular Health Metrics Are Associated with Reduced Severity of Hepatic Steatosis and Liver Fibrosis Detected by Transient Elastography. Nutrients 14:24, pages 5344.
Crossref
Crossref
Jincheng Wang, Tao Qin, Jinyu Sun, Shiwu Li, Lihua Cao & Xiaojie Lu. (2022) Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease. Frontiers in Physiology 13.
Crossref
Crossref
Seong-Woo Choi, Sun-Seog Kweon, Young-Hoon Lee, So-Yeon Ryu, Hae-Sung Nam & Min-Ho Shin. (2022) Association of liver fibrosis biomarkers with overall and CVD mortality in the Korean population: The Dong-gu study. PLOS ONE 17:12, pages e0277729.
Crossref
Crossref
Sara Karjoo, Anthony Auriemma, Teresa Fraker & Harold Edward Bays. (2022) Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 3, pages 100027.
Crossref
Crossref
Yu-tian Cao, Liu-lan Xiang, Fang Qi, Yu-juan Zhang, Yi Chen & Xi-qiao Zhou. (2022) Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. eClinicalMedicine 51, pages 101547.
Crossref
Crossref
Yilian Xie, Weiliang Kong, Xuepeng Wang & Zhouxiao Wu. (2022) Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes. BMC Endocrine Disorders 22:1.
Crossref
Crossref
Ferenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, Arjun Narayan Ajmer Jayaswal, Michael Trauner, Jerome Boursier, Céline Fournier, Katharina Staufer, Rudolf E Stauber, Elisabetta Bugianesi, Ramy Younes, Silvia Gaia, Monica Lupșor-Platon, Salvatore Petta, Toshihide Shima, Takeshi Okanoue, Sanjiv Mahadeva, Wah-Kheong Chan, Peter J Eddowes, Gideon M Hirschfield, Philip Noel Newsome, Vincent Wai-Sun Wong, Victor de Ledinghen, Jiangao Fan, Feng Shen, Jeremy F Cobbold, Yoshio Sumida, Akira Okajima, Jörn M Schattenberg, Christian Labenz, Won Kim, Myoung Seok Lee, Johannes Wiegand, Thomas Karlas, Yusuf Yılmaz, Guruprasad Padur Aithal, Naaventhan Palaniyappan, Christophe Cassinotto, Sandeep Aggarwal, Harshit Garg, Geraldine J Ooi, Atsushi Nakajima, Masato Yoneda, Marianne Ziol, Nathalie Barget, Andreas Geier, Theresa Tuthill, M. Julia Brosnan, Quentin Mark Anstee, Stefan Neubauer, Stephen A. Harrison, Patrick M Bossuyt & Michael Pavlides. (2022) Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut 71:5, pages 1006-1019.
Crossref
Crossref
Dong Hyeon Lee, Se Un Sung, Yun Kyu Lee, Ik Hyeon Lim, Heejoon Jang, Sae Kyoung Joo, Jeong Hwan Park, Mee Soo Chang, Young Ho So & Won Kim. (2022) A sequential approach using the age‐adjusted fibrosis‐4 index and vibration‐controlled transient elastography to detect advanced fibrosis in Korean patients with non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 55:8, pages 994-1007.
Crossref
Crossref
Haluk Tarık KANİ, Çağlayan KEKLİKKIRAN, İlkay ERGENÇ & Yusuf YILMAZ. (2022) Evaluation of spleen stiffness in healthy population: a vibration-controlled transient elastography study. Journal of Health Sciences and Medicine 5:2, pages 689-692.
Crossref
Crossref
Eda Kaya & Yusuf Yilmaz. (2022) Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease. Therapeutic Advances in Endocrinology and Metabolism 13, pages 204201882211396.
Crossref
Crossref
Hakan Guveli, Emre Batuhan Kenger, Tugce Ozlu, Eda Kaya & Yusuf Yilmaz. (2021) Macro- and micronutrients in metabolic (dysfunction) associated fatty liver disease: association between advanced fibrosis and high dietary intake of cholesterol/saturated fatty acids. European Journal of Gastroenterology & Hepatology 33:1S, pages e390-e394.
Crossref
Crossref
Emmanuel Anandraj Selvaraj, Ferenc Emil Mózes, Arjun Narayan Ajmer Jayaswal, Mohammad Hadi Zafarmand, Yasaman Vali, Jenny A. Lee, Christina Kim Levick, Liam Arnold Joseph Young, Naaventhan Palaniyappan, Chang-Hai Liu, Guruprasad Padur Aithal, Manuel Romero-Gómez, M. Julia Brosnan, Theresa A. Tuthill, Quentin M. Anstee, Stefan Neubauer, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin Anstee, Ann Daly, Katherine Johnson, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bedossa, Fiona Oakley, Heather Cordell, Chris Day, Kristy Wonders, Patrick Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Vlad Ratziu, Karine Clement, Raluca Pais, Detlef Schuppan, Jörn Schattenberg, Toni Vidal-Puig, Michele Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Matej Oresic, Tuulia Hyötyläinen, Aiden McGlinchey, Jose M. Mato, Oscar Millet, Jean-François Dufour, Annalisa Berzigotti, Michael Pavlides, Stephen Harrison, Stefan Neubauer, Jeremy Cobbold, Ferenc Mozes, Salma Akhtar, Rajarshi Banerjee, Matt Kelly, Elizabeth Shumbayawonda, Andrea Dennis, Charlotte Erpicum, Manuel Romero-Gómez, Emilio Gómez-González, Javier Ampuero, Javier Castell, Rocío Gallego-Durán, Isabel Fernández, Rocío Montero-Vallejo, Morten Karsdal, Elisabeth Erhardtsen, Daniel Rasmussen, Diana Julie Leeming, Mette Juul Fisker, Antonia Sinisi, Kishwar Musa, Fay Betsou, Estelle Sandt, Manuela Tonini, Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi, Fabio Marra, Amalia Gastaldelli, Gianluca Svegliati, Jérôme Boursier, Sven Francque, Luisa Vonghia, Mattias Ekstedt, Stergios Kechagias, Hannele Yki-Jarvinen, Panu Luukkonen, Saskia van Mil, George Papatheodoridis, Helena Cortez-Pinto, Luca Valenti, Salvatore Petta, Luca Miele, Andreas Geier, Christian Trautwein, Guru Aithal, Paul Hockings, Philip Newsome, David Wenn, Cecília Maria Pereira Rodrigues, Pierre Chaumat, Rémy Hanf, Aldo Trylesinski, Pablo Ortiz, Kevin Duffin, Julia Brosnan, Theresa Tuthill, Euan McLeod, Judith Ertle, Ramy Younes, Rachel Ostroff, Leigh Alexander, Mette Skalshøi Kjær, Lars Friis Mikkelsen, Maria-Magdalena Balp, Clifford Brass, Lori Jennings, Miljen Martic, Juergen Loeffler, Guido Hanauer, Sudha Shankar, Céline Fournier, Kay Pepin, Richard Ehman, Joel Myers, Gideon Ho, Richard Torstenson, Rob Myers & Lynda Doward. (2021) Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. Journal of Hepatology 75:4, pages 770-785.
Crossref
Crossref
Andreas Geier, Dina Tiniakos, Helmut Denk & Michael Trauner. (2021) From the origin of NASH to the future of metabolic fatty liver disease. Gut 70:8, pages 1570-1579.
Crossref
Crossref
Anne-Marieke Van Dijk, Yasaman Vali, Anne Linde Mak, Jenny Lee, Maarten E. Tushuizen, Mohammad Hadi Zafarmand, Quentin M. Anstee, M. Julia Brosnan, Max Nieuwdorp, Patrick M. Bossuyt & Adriaan G. Holleboom. (2021) Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 10:13, pages 2910.
Crossref
Crossref
Amedeo Lonardo, Juan Pablo Arab & Marco Arrese. (2021) Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management. Advances in Therapy 38:5, pages 2130-2158.
Crossref
Crossref
Evangelia Makri, Antonis Goulas & Stergios A. Polyzos. (2021) Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. Archives of Medical Research 52:1, pages 25-37.
Crossref
Crossref
Ahmed M. F. Mansour, Essam M. Bayoumy, Ahmed M. ElGhandour, Mohamed Darwish El-Talkawy, Sameh M. Badr & Ahmed El-Metwally Ahmed. (2020) Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease. Egyptian Liver Journal 10:1.
Crossref
Crossref
Konstantinos C. Fragkos, María Claudia Picasso Bouroncle, Shankar Kumar, Lucy Caselton, Alex Menys, Alan Bainbridge, Stuart A. Taylor, Francisco Torrealdea, Tomoko Kumagai, Simona Di Caro, Farooq Rahman, Jane Macnaughtan, Manil D. Chouhan & Shameer Mehta. (2020) Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility Study. Nutrients 12:7, pages 2151.
Crossref
Crossref
Hamid Vahedi, Niloufar Bavafaetousi, Pouneh Zolfaghari, Maryam Yarmohammadi & Mohammad Bagher Sohrabi. (2020) Association between serum folate levels and fatty liver disease. Clinical Nutrition Experimental 29, pages 30-35.
Crossref
Crossref
Maeva Guillaume, Valerie Moal, Cyrielle Delabaudiere, Floraine Zuberbuhler, Marie-Angèle Robic, Adrien Lannes, Sophie Metivier, Frederic Oberti, Pierre Gourdy, Isabelle Fouchard-Hubert, Janick Selves, Sophie Michalak, Jean-Marie Peron, Paul Cales, Christophe Bureau & Jerome Boursier. (2019)
Direct comparison of the specialised blood fibrosis tests FibroMeter
V2G
and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres
. Alimentary Pharmacology & Therapeutics 50:11-12, pages 1214-1222.
Crossref
Crossref
J.A. Weintraub, G. Lopez Mitnik & B.A. Dye. (2019) Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United States. Journal of Dental Research 98:11, pages 1219-1226.
Crossref
Crossref
Tannaz Jamialahmadi, Mohsen Nematy, Ali Jangjoo, Ladan Goshayeshi, Reza Rezvani, Kamran Ghaffarzadegan, Mehdi Jabbari Nooghabi, Payman Shalchian, Mahtab Zangui, Zeinab Javid, Saeid Doaei & Farnood Rajabzadeh. (2019) Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy. Obesity Surgery 29:8, pages 2585-2592.
Crossref
Crossref
Biaoyang LinYingying MaShengjun WuYunhua LiuLonggen LiuLihua Wu. (2019) Novel Serum Biomarkers for Noninvasive Diagnosis and Screening of Nonalcoholic Fatty Liver Disease-Related Hepatic Fibrosis. OMICS: A Journal of Integrative Biology 23:4, pages 181-189.
Crossref
Crossref
Zhifeng You, Lyu Zhou, Wenjing Li, Chenyu Huang & Yanan Du. (2019) Mechanical microenvironment as a key cellular regulator in the liver. Acta Mechanica Sinica 35:2, pages 289-298.
Crossref
Crossref
Adam J. Buckley, E. Louise Thomas, Nader Lessan, Francesca M. Trovato, Guglielmo M. Trovato & Simon D. Taylor-Robinson. (2018) Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpoints. Diabetes Research and Clinical Practice 144, pages 144-152.
Crossref
Crossref
Christina N. Katsagoni, George V. Papatheodoridis, Panagiota Ioannidou, Melanie Deutsch, Alexandra Alexopoulou, Nikolaos Papadopoulos, Maria-Vasiliki Papageorgiou, Elizabeth Fragopoulou & Meropi D. Kontogianni. (2018) Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. British Journal of Nutrition 120:2, pages 164-175.
Crossref
Crossref
Elliot B. Tapper & Rohit Loomba. (2018) Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD. Nature Reviews Gastroenterology & Hepatology 15:5, pages 274-282.
Crossref
Crossref
G. J. Ooi, S. Mgaieth, G. D. Eslick, P. R. Burton, W. W. Kemp, S. K. Roberts & W. A. Brown. (2018) Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese. Obesity Reviews 19:2, pages 281-294.
Crossref
Crossref
Claudio Tana, Cosima Schiavone, Andrea Ticinesi, Fulvio Lauretani, Antonio Nouvenne, Christoph Frank Dietrich & Tiziana Meschi. (2018) Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective. International Journal of Immunopathology and Pharmacology 32, pages 205873841878137.
Crossref
Crossref
Jessica Wisocky & Sonali Paul. (2017) The rising incidence of nonalcoholic fatty liver disease. The Nurse Practitioner 42:7, pages 14-20.
Crossref
Crossref
Bing WangJing ZengQi Gu. (2017) Exercise restores bioavailability of hydrogen sulfide and promotes autophagy influx in livers of mice fed with high-fat diet. Canadian Journal of Physiology and Pharmacology 95:6, pages 667-674.
Crossref
Crossref
Geraldine J. Ooi, Paul R. Burton, Lisa Doyle, John M. Wentworth, Prithi S. Bhathal, Ken Sikaris, Michael A. Cowley, Stuart K. Roberts, William Kemp, Paul E. O’Brien & Wendy A. Brown. (2016) Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese. Obesity Surgery 27:1, pages 115-125.
Crossref
Crossref
Martin L. Decaris, Kelvin W. Li, Claire L. Emson, Michelle Gatmaitan, Shanshan Liu, Yenny Wang, Edna Nyangau, Marc Colangelo, Thomas E. Angel, Carine Beysen, Jeffrey Cui, Carolyn Hernandez, Len Lazaro, David A. Brenner, Scott M. Turner, Marc K. Hellerstein & Rohit Loomba. (2016) Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood. Hepatology 65:1, pages 78-88.
Crossref
Crossref
Guanliang Chen, Yinhua Ni, Naoto Nagata, Liang Xu & Tsuguhito Ota. (2016) Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 17:9, pages 1379.
Crossref
Crossref
Hye Won Lee, Soo Young Park, Seung Up Kim, Jae Young Jang, Hana Park, Ja Kyung Kim, Chun Kyon Lee, Young Eun Chon & Kwang-Hyub Han. (2016) Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease. PLOS ONE 11:6, pages e0157358.
Crossref
Crossref
Jiawei LiPaul CorderoVi NguyenJude A. Oben. (2016) The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease. Integrative Medicine Insights 11, pages IMI.S31451.
Crossref
Crossref
Elif Dincses & Yusuf Yilmaz. (2015) Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 27:10, pages 1149-1153.
Crossref
Crossref